Advertisement

Cancer Causes & Control

, Volume 30, Issue 10, pp 1075–1085 | Cite as

Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE)

  • Nicolas Vidart d’Egurbide BagazgoïtiaEmail author
  • Helen D. Bailey
  • Laurent Orsi
  • Léa Guerrini-Rousseau
  • Anne-Isabelle Bertozzi
  • Cécile Faure-Conter
  • Pierre Leblond
  • Isabelle Pellier
  • Claire Freycon
  • François Doz
  • Stéphanie Puget
  • Stéphane Ducassou
  • Brigitte Lacour
  • Jacqueline Clavel
Original Paper

Abstract

Purpose

Although some specific genetic syndromes such as neurofibromatosis (NF) have been identified as risk factor of childhood brain tumors (CBT), the potential role of inherited susceptibility in CBT has yet to be elucidated.

Methods

To further investigate this, we conducted a pooled analysis of two nationwide case–control studies ESCALE and ESTELLE. The mothers of 509 CBT cases and 3,102 controls aged under 15 years who resided in France at diagnosis/interview, frequency-matched by age and gender, responded to a telephone interview conducted by trained interviewers. Pooled odds ratio (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression.

Results

CBT was significantly associated with the family history of cancer in relatives (OR 1.2, 95% CI 1.0–1.5). The OR was slightly higher for maternal relatives than for paternal relatives, and when at least two relatives had a history of cancer. CBT was significantly associated with a family history of brain tumor (OR 2.1, 95% CI 1.3–3.7). This association seemed stronger for first-degree relatives (mother, father, and siblings), for whom, by contrast, no association was seen for cancers other than CBT. No specificity by CBT subtypes or by age of the children were found for any of these findings.

Conclusion

Our findings support the hypothesis of a familial susceptibility of CBT, not due to being a known NF carrier.

Keywords

Childhood cancer Brain tumors Family history of cancer Family history of brain tumor Risk factors Case–control studies France 

Abbreviations

CBT

Childhood brain tumors

CI

Confidence interval

CMMRD

Constitutional mismatch repair deficiency

ESCALE

Etude Sur les Cancers et les Leucémies de l'Enfant (Study of childhood cancers and leukemias)

ESTELLE

Etude Sur les Tumeurs Embryonnaires, Leucémies et Lymphomes de l’Enfant (Study of childhood embryonal tumors, leukemias and lymphomas)

ICCC-3

International Classification of Childhood Cancer 3rd Edition

NF

Neurofibromatosis

OR

Odds ratio

RNCE

Registre National des Cancers de l’Enfant (National Registry of Childhood Cancers)

SFCE

Société Française de lutte contre les Cancers et les leucémies de l’Enfant et de l’Adolescent (French Society for the fight against cancers and leukemia in childhood and adolescence)

Notes

Acknowledgements

The authors would also like to thank all of the Société Française de lutte contre les Cancers de l’Enfant et de l’Adolescent (SFCE) principal investigators: Claire Berger (Centre Hospitalier Universitaire, Saint-Etienne), Christophe Bergeron (Centre Léon Bérard, Lyon), Jean-Louis Bernard (Hôpital La Timone, Marseille), Yves Bertrand (Hôpital Debrousse, Lyon), Pierre Bordigoni (Centre Hospitalier Universitaire, Nancy), Patrick Boutard (Centre Hospitalier Régional Universitaire, Caen), Pascal Chastagner (Centre Hospitalier Universitaire, Nancy), Philippe Colombat (Centre Gatien de Clocheville, Tours), Gérard Couillault (Hôpital d’Enfants, Dijon), Anne-Sophie Defachelles (Oscar Lambret Comprehensive Cancer Center, Lille), François Demeocq (Hôpital Hôtel-Dieu, Clermont-Ferrand), Jean Michon (Institut Curie, Paris), Alain Fischer (Hôpital des Enfants Malades, Paris), Virginie Gandemer (Centre Hospitalier Universitaire – Hôpital Sud, Rennes), Stéphanie Haouy (Hôpital Arnaud de Villeneuve, Montpellier), Jean-Pierre Lamagnere (Centre Gatien de Clocheville, Tours), Françoise Lapierre (Centre Hospitalier Universitaire Jean Bernard, Poitiers), Patrick Lutz (Hôpital de Hautepierre, Strasbourg), Geneviève Margueritte (Hôpital Arnaud de Villeneuve, Montpellier), Françoise Mechinaud (Hôpital Mère et Enfants, Nantes), Gérard Michel (Hôpital La Timone, Marseille), Frédéric Millot (Centre Hospitalier Universitaire Jean Bernard, Poitiers), Philippe le Moine (Hôpital Morvan, Brest), Martine Münzer (American Memorial Hospital, Reims), Brigitte Nelken (Hôpital Jeanne de Flandre, Lille), Brigitte Pautard (Centre Hospitalier Universitaire, Amiens), Yves Perel (Hôpital Pellegrin Tripode, Bordeaux), Alain Pierre-Kahn (Hôpital Enfants Malades, Paris), Christophe Piguet (Centre Hospitalier Régional Universitaire, Limoges), Dominique Plantaz (Centre Hospitalier Universitaire, Grenoble), Emmanuel Plouvier (Centre Hospitalier Régional, Besançon), Marilyne Poiree (Fondation Lenval, Nice), Xavier Rialland (Centre Hospitalier Universitaire, Angers), Alain Robert (Hôpital des Enfants, Toulouse), Hervé Rubie (Hôpital des Enfants, Toulouse), Christian Sainte Rose (Centre Hospitalier Universitaire Necker, Paris), Nicolas Sirvent (Hôpital Arnaud de Villeneuve, Montpellier), Christine Soler (Fondation Lenval, Nice), Dominique Valteau-Couanet (Gustave Roussy, Villejuif), and Jean-Pierre Vannier (Hôpital Charles Nicolle, Rouen). The authors thank all families for their generous participation.

Funding

The ESCALE and ESTELLE studies were supported by Grants from INSERM, the Ligue National Contre le Cancer (LNCC), the Fondation de France, the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS), the Agence Française de Sécurité Sanitaire de l’Environnement et du Travail (AFSSET), the Association pour la Recherche sur le Cancer (ARC), the Agence Française de Sécurité Sanitaire des Produits de Santé (ANSM), the Agence Française de Sécurité Sanitaire de l’Environnement et du Travail (ANSES), the association Cent pour sang la vie, the Institut National du Cancer (INCa), and the Agence Nationale de la Recherche (ANR), and Cancéropôle Ile de France. Nicolas Vidart d’Egurbide Bagazgoïtia’s PhD scholarship is supported by the Institut National du Cancer (INCa_11338).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Desandes E, Guissou S, Chastagner P, Lacour B (2014) Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors. Neuro Oncol 16:975–983.  https://doi.org/10.1093/neuonc/not309 CrossRefGoogle Scholar
  2. 2.
    Mellemkjaer L, Hasle H, Gridley G et al (2006) Risk of cancer in children with the diagnosis immaturity at birth. Paediatr Perinat Epidemiol 20:231–237.  https://doi.org/10.1111/j.1365-3016.2006.00717.x CrossRefGoogle Scholar
  3. 3.
    Farrell CJ, Plotkin SR (2007) genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von hippel-lindau, and other syndromes. Neurol Clin 25:925–946.  https://doi.org/10.1016/j.ncl.2007.07.008 CrossRefGoogle Scholar
  4. 4.
    Hottinger AF, Khakoo Y (2009) Neurooncology of familial cancer syndromes. J Child Neurol 24:1526–1535.  https://doi.org/10.1177/0883073809337539 CrossRefGoogle Scholar
  5. 5.
    Stefanaki K, Alexiou GA, Stefanaki C, Prodromou N (2012) Tumors of central and peripheral nervous system associated with inherited genetic syndromes. Pediatr Neurosurg 48:271–285.  https://doi.org/10.1159/000351546 CrossRefGoogle Scholar
  6. 6.
    Bourdeaut F, Miquel C, Richer W et al (2014) Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 medulloblastoma. Pediatr Blood Cancer 61:383–386.  https://doi.org/10.1002/pbc.24765 CrossRefGoogle Scholar
  7. 7.
    Wimmer K, Kratz CP, Vasen HFA et al (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD). J Med Genet 51:355–365.  https://doi.org/10.1136/jmedgenet-2014-102284 CrossRefGoogle Scholar
  8. 8.
    Baldwin RT, Preston-Martin S (2004) Epidemiology of brain tumors in childhood–a review. Toxicol Appl Pharmacol 199:118–131.  https://doi.org/10.1016/j.taap.2003.12.029 CrossRefGoogle Scholar
  9. 9.
    Zhang J, Walsh MF, Wu G et al (2015) Germline mutations in predisposition genes in pediatric cancer. N Engl J Med 373:2336–2346.  https://doi.org/10.1056/NEJMoa1508054 CrossRefGoogle Scholar
  10. 10.
    Kuijten RR, Bunin GR, Nass CC, Meadows AT (1990) Gestational and familial risk factors for childhood astrocytoma: results of a case–control study. Cancer Res 50:2608–2612Google Scholar
  11. 11.
    Bondy ML, Lustbader ED, Buffler PA et al (1991) Genetic epidemiology of childhood brain tumors. Genet Epidemiol 8:253–267.  https://doi.org/10.1002/gepi.1370080406 CrossRefGoogle Scholar
  12. 12.
    Gold EB, Leviton A, Lopez R et al (1994) The role of family history in risk of childhood brain tumors. Cancer 73:1302–1311CrossRefGoogle Scholar
  13. 13.
    Smulevich VB, Solionova LG, Belyakova SV (1999) Parental occupation and other factors and cancer risk in children: I. Study methodology and non-occupational factors. Int J Cancer 83:712–717.  https://doi.org/10.1002/(SICI)1097-0215(19991210)83:6%3c712:AID-IJC2%3e3.0.CO;2-D CrossRefGoogle Scholar
  14. 14.
    Farwell J, Flannery JT (1984) Cancer in relatives of children with central-nervous-system neoplasms. N Engl J Med 311:749–753.  https://doi.org/10.1056/NEJM198409203111201 CrossRefGoogle Scholar
  15. 15.
    Hemminki K, Li X, Vaittinen P, Dong C (2000) Cancers in the first-degree relatives of children with brain tumours. Br J Cancer 83:407–411.  https://doi.org/10.1054/bjoc.2000.1252 CrossRefGoogle Scholar
  16. 16.
    Searles Nielsen S, Mueller BA, Preston-Martin S et al (2008) Family cancer history and risk of brain tumors in children: results of the SEARCH international brain tumor study. Cancer Causes Control 19:641–648.  https://doi.org/10.1007/s10552-008-9128-7 CrossRefGoogle Scholar
  17. 17.
    Hemminki K, Tretli S, Olsen JH et al (2010) Familial risks in nervous system tumours: joint Nordic study. Br J Cancer 102:1786–1790.  https://doi.org/10.1038/sj.bjc.6605708 CrossRefGoogle Scholar
  18. 18.
    Crump C, Sundquist J, Sieh W et al (2015) Perinatal and familial risk factors for brain tumors in childhood through young adulthood. Cancer Res 75:576–583.  https://doi.org/10.1158/0008-5472.CAN-14-2285 CrossRefGoogle Scholar
  19. 19.
    Rudant J, Menegaux F, Leverger G et al (2007) Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE). Environ Health Perspect 115:1787–1793.  https://doi.org/10.1289/ehp.10596 CrossRefGoogle Scholar
  20. 20.
    Ajrouche R, Rudant J, Orsi L et al (2014) Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE study. Cancer Causes Control 25:1283–1293.  https://doi.org/10.1007/s10552-014-0429-8 CrossRefGoogle Scholar
  21. 21.
    Vidart d’Egurbide Bagazgoïtia N, Bailey HD, Orsi L et al (2018) Maternal residential pesticide use during pregnancy and risk of malignant childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE). Int J Cancer 142:489–497.  https://doi.org/10.1002/ijc.31073 CrossRefGoogle Scholar
  22. 22.
    Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International classification of childhood cancer, third edition. Cancer 103:1457–1467. https://doi.org/10.1002/cncr.20910
  23. 23.
    Del Risco Kollerud R, Blaasaas KG, Claussen B, et al (2018) Family history of cancer and the risk of childhood solid tumours: a Norwegian nationwide register-based cohort study. Br J Cancer. https://doi.org/10.1038/bjc.2017.493
  24. 24.
    Bondy ML, Strom SS, Colopy MW et al (1994) Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 47:89–96.  https://doi.org/10.1016/0895-4356(94)90037-X CrossRefGoogle Scholar
  25. 25.
    Fiederling J, Shams AZ, Haug U Validity of self-reported family history of cancer: a systematic literature review on selected cancers. Int J Cancer 139:1449–1460.  https://doi.org/10.1002/ijc.30203
  26. 26.
    Airewele G, Adatto P, Cunningham J et al (1998) Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst 90:543–544.  https://doi.org/10.1093/jnci/90.7.543 CrossRefGoogle Scholar
  27. 27.
    Ivanovich J, Babb S, Goodfellow P et al (2002) Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer. Clin Cancer Res 8:1849–1856Google Scholar
  28. 28.
    King TM, Tong L, Pack RJ et al (2002) Accuracy of family history of cancer as reported by men with prostate cancer. Urology 59:546–550.  https://doi.org/10.1016/S0090-4295(01)01598-9 CrossRefGoogle Scholar
  29. 29.
    Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24:190–198.  https://doi.org/10.1016/S0749-3797(02)00593-7 CrossRefGoogle Scholar
  30. 30.
    Infante-Rivard C, Roncarolo F, Doucette K (2012) Reliability of cancer family history reported by parents in a case–control study of childhood leukemia. Cancer Causes Control 23:1665–1672.  https://doi.org/10.1007/s10552-012-0045-4 CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.CRESS, UMR1153, Inserm, Paris Descartes UniversityParisFrance
  2. 2.Telethon Kids InstituteThe University of Western AustraliaPerthAustralia
  3. 3.Gustave Roussy, Département de cancérologie de l’enfant et de L’adolescentVillejuifFrance
  4. 4.Unité d’Hémato-Immuno-Oncologie pédiatrique, Pôle Pédiatrique, CHU ToulouseToulouseFrance
  5. 5.Institut d’hématologie et d’oncologie pédiatrique, IHOPe, Centre Léon BérardLyonFrance
  6. 6.Pediatric Oncology UnitOscar Lambret Comprehensive Cancer CenterLilleFrance
  7. 7.Unité immuno-hémato-oncopédiatrie, CHU d’AngersAngersFrance
  8. 8.Clinique de pédiatrie, Hôpital Couple Enfant, CHU Grenoble-AlpesGrenobleFrance
  9. 9.Département de Pédiatrie -Adolescents Et Jeunes Adultes, Institut CurieEt Université Paris DescartesParisFrance
  10. 10.Service de Neurochirurgie pédiatrique, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne Paris CitéParisFrance
  11. 11.Service d’onco-hématologie pédiatrique, Hôpital Pellegrin TripodeBordeauxFrance
  12. 12.RNCE - National Registry of Childhood Cancers, InsermVillejuif and CHU de NancyFrance

Personalised recommendations